Overview
Microcytic hypochromic anemia is characterized by decreased hemoglobin, PCV, MCV, MCH, and MCHC, with red cells appearing smaller (microcytic) and paler (hypochromic) than normal on the peripheral smear. It is the most commonly encountered anemia pattern worldwide.
This lesson covers the pathophysiology of normal iron metabolism, the world's most common anemia — iron deficiency — as well as the key differential diagnoses: anemia of chronic disease, beta thalassemia minor, and sideroblastic anemia, each of which must be distinguished using a combination of red cell indices, peripheral smear, and biochemical iron studies.
Learning Objectives
After this lesson you will be able to…- Describe normal iron distribution, absorption, transport, and loss in the body
- List the causes and clinical features of iron deficiency anemia
- Interpret the iron profile (serum iron, TIBC, transferrin saturation, ferritin)
- Differentiate iron deficiency anemia from anemia of chronic disease, thalassemia minor, and sideroblastic anemia
- Describe the laboratory diagnosis of each microcytic hypochromic anemia
Clinical Story
Why This MattersA 28-year-old woman with heavy menstrual bleeding presents with fatigue, brittle nails, and a craving to chew ice. Her CBC shows a microcytic hypochromic anemia. The laboratory technologist must decide which additional tests — iron studies or hemoglobin HPLC — will correctly distinguish simple iron deficiency from a thalassemia trait that might otherwise be mistaken for it and inappropriately treated with iron.
Core Concepts
Around 60% of body iron resides in hemoglobin (the erythron); the remainder is in myoglobin, enzymes, and storage as ferritin and hemosiderin in macrophages. Dietary iron intake is 10–15 mg/day, but only 5–10% (~3.5 mg/day) is absorbed, mainly in the proximal small intestine. Absorbed iron is transported bound to transferrin (normally ~35% saturated) to developing red cells. Daily requirements are 1 mg (men), 1.5 mg (women), and 2 mg (pregnancy/lactation). Iron is lost through epithelial shedding and, in women, through menstruation.
The most common anemia worldwide, iron deficiency results from decreased intake, decreased absorption, chronic blood loss, or increased requirement. It develops in three stages: prelatent (depleted stores, normal serum iron), latent (exhausted stores, mild serum iron fall, not yet anemic), and anemia (symptomatic fall in hemoglobin). Clinical features include fatigue, pica, angular stomatitis, koilonychia (spoon nails), and glossitis. Laboratory findings show decreased Hb/PCV/RBC, decreased MCV/MCH/MCHC, increased RDW (17–23%), and often reactive thrombocytosis.
In iron deficiency: serum iron is decreased (normal 60–170 µg/dL), TIBC is increased (normal 250–400 µg/dL), transferrin saturation is decreased (normal 16–50%), and serum ferritin is decreased (normal 15–300 µg/L males, 15–200 µg/L females). This pattern contrasts sharply with anemia of chronic disease, where serum iron and TIBC are both decreased but ferritin is normal or increased, reflecting adequate but unavailable iron stores due to inflammatory cytokines blocking mobilization.
Beta thalassemia minor shows mildly decreased Hb/PCV with an increased RBC count, decreased MCV/MCH with normal/mildly decreased MCHC, only mildly raised RDW, target cells on smear, and a normal iron profile; diagnosis rests on HPLC showing raised HbA2 (3.5–7.0%). Sideroblastic anemia results from defective heme synthesis with iron trapped in mitochondria, producing ringed sideroblasts on Prussian blue bone marrow stain; serum iron and ferritin are increased, TIBC decreased — the opposite biochemical pattern from iron deficiency.
Laboratory Principle
Microcytic hypochromic anemias share a common final pathway — insufficient hemoglobin synthesis per red cell — but arise from four distinct mechanisms: absolute iron lack (iron deficiency), iron trapped and unavailable due to inflammation (anemia of chronic disease), reduced globin chain production (thalassemia), or defective incorporation of adequate iron into heme (sideroblastic anemia). The iron profile and hemoglobin analysis together allow these mechanistically different causes to be distinguished even when the red cell indices look superficially similar.
Equipment Required
Reagents & Materials
| Reagent / Material | Concentration / Grade | Purpose | Storage |
|---|---|---|---|
| Prussian Blue (Perls') Stain | Potassium ferrocyanide/HCl | Demonstrates storage iron and ringed sideroblasts | Room temperature, prepare fresh |
| Serum Iron/TIBC Reagent Kit | Colorimetric commercial kit | Quantifies serum iron and iron-binding capacity | 2–8°C |
| Ferritin Immunoassay Kit | Chemiluminescent/ELISA | Quantifies iron stores | 2–8°C |
| HPLC Buffer System | Manufacturer-specific buffers | Hemoglobin A2/F quantification for thalassemia | As per manufacturer |
Step-by-Step Procedure
Draw fasting venous blood for CBC, iron studies (morning sample preferred due to diurnal variation), and HPLC if indicated.
Measure Hb, PCV, RBC count and calculate MCV, MCH, MCHC, RDW.
Assess for microcytosis, hypochromia, anisopoikilocytosis, and target cells.
Measure serum iron, TIBC, calculate transferrin saturation, and measure serum ferritin.
If iron studies are normal despite microcytosis, perform HPLC to assess HbA2 and HbF for thalassemia trait diagnosis.
Flow Diagram
Quality Control
Iron and ferritin assays should be run with commercial control sera at low, normal, and high levels each day of testing; Prussian blue staining should include a known iron-positive marrow control slide to confirm reagent reactivity.
Participation in external quality assessment for iron studies and hemoglobinopathy HPLC ensures the laboratory's results remain accurate and comparable, particularly important given the overlapping presentations of iron deficiency and thalassemia trait.
Reference Values
Normal Ranges⚠️ Reference ranges may vary between laboratories. Always apply your laboratory's established reference intervals.
Clinical Interpretation
| Finding | Possible Significance | Action / Follow-up |
|---|---|---|
| Low serum iron, high TIBC, low ferritin | Iron deficiency anemia | Initiate oral iron therapy; investigate and treat source of blood loss |
| Low serum iron, low TIBC, normal/high ferritin | Anemia of chronic disease | Treat underlying chronic inflammatory/infective/neoplastic disorder |
| Normal iron profile, raised HbA2 on HPLC | Beta thalassemia minor | Genetic counseling; screen spouse before family planning |
Common Errors & How to Avoid Them
Cause: Both conditions present with microcytic hypochromic anemia, but treating thalassemia trait with iron is unnecessary and can lead to iron overload over time.
Prevention: Always check iron studies first; if normal despite microcytosis, proceed to HPLC to rule out thalassemia before starting iron therapy.
Cause: Serum ferritin is an acute phase reactant and can appear falsely normal or elevated in iron-deficient patients who also have concurrent infection or inflammation.
Prevention: Interpret ferritin alongside CRP or other inflammatory markers, and consider soluble transferrin receptor testing in ambiguous cases.
Cause: Ringed sideroblasts can be subtle and require a well-prepared Prussian blue stain with adequate marrow particles to be reliably identified.
Prevention: Ensure adequate marrow aspirate particles are stained and examined systematically before excluding sideroblastic anemia.
Laboratory Tips from the Bench
A raised RBC count in the setting of microcytic anemia points strongly toward thalassemia trait rather than iron deficiency, since iron deficiency more typically reduces the RBC count alongside the Hb.
Always collect the serum iron sample in the morning, since serum iron shows significant diurnal variation and afternoon samples can be misleadingly low.
Remember the iron profile pattern with 'IDA drains the tank, ACD locks the tank': iron deficiency shows low ferritin (true depletion), while anemia of chronic disease shows normal/high ferritin (iron present but locked away).
Important Notes
Unlike iron deficiency, thalassemia minor patients have a normal iron profile and giving unnecessary iron supplementation risks long-term iron overload without correcting the anemia.
With beta thalassemia gene carrier rates of 3–15% in parts of India, correctly distinguishing thalassemia trait from iron deficiency is essential for genetic counseling and premarital screening programs.
Interactive Quiz
Test Your KnowledgeFlashcards
Tap to flipClick or tap any card to reveal the answer. Use arrow keys to navigate in single-card mode.
Clinical Case Study
Apply Your KnowledgePresents with fatigue, brittle nails, and an unusual craving to chew on ice cubes for the past two months. She reports heavy, prolonged menstrual periods for over a year.
The markedly low ferritin in the presence of a low serum iron and elevated TIBC confirms true iron store depletion, consistent with chronic blood loss from menorrhagia driving iron deficiency anemia.
- →Pica (ice craving) and koilonychia are classic clinical clues to chronic iron deficiency.
- →A markedly low ferritin is the most specific single marker distinguishing iron deficiency from other microcytic anemias.
- →The underlying cause of blood loss (menorrhagia) must be investigated and managed alongside iron replacement.
Frequently Asked Questions
In iron deficiency the body increases transferrin synthesis to maximize its chance of capturing scarce iron, raising TIBC, whereas in chronic disease inflammatory cytokines suppress transferrin synthesis even though iron stores (ferritin) remain adequate or elevated.
Yes, and this combination can produce a confusing, sometimes near-normal HbA2 result on HPLC, since iron deficiency can lower HbA2 slightly — repeat HPLC after correcting iron deficiency is recommended in such ambiguous cases.
The diagnosis of iron deficiency anemia is reliably made from the complete blood count, peripheral smear, and biochemical iron profile, making invasive bone marrow examination unnecessary except in atypical or unresponsive cases.
Quick Revision
10-Minute ReviewKey Takeaways
- Microcytic hypochromic anemia has four principal causes: iron deficiency, chronic disease, thalassemia minor, and sideroblastic anemia.
- Normal iron metabolism depends on adequate intake, absorption, transferrin transport, and storage as ferritin/hemosiderin.
- The iron profile (serum iron, TIBC, transferrin saturation, ferritin) is the key tool to distinguish these causes.
- Iron deficiency shows depleted stores (low ferritin); chronic disease shows locked-away but adequate stores (normal/high ferritin).
- Thalassemia minor is confirmed by HPLC showing elevated HbA2 with a normal iron profile.
- Sideroblastic anemia is confirmed by bone marrow ringed sideroblasts with an iron-overloaded biochemical profile.
Competency Checklist
Track Your MasteryReferences
- National Institute of Open Schooling. Hematology and Blood Bank Technique, Lesson 16: Microcytic Hypochromic Anemia.
- Dacie JV, Lewis SM. Practical Haematology. 11th ed. Churchill Livingstone.
- Hoffbrand AV, Moss PAH. Essential Haematology. 7th ed. Wiley-Blackwell.